This study aimed to evaluate the effect of levodopa on cerebral arteries and gray matter cerebral blood flow (CBF) in patients with Parkinson’s disease (PD). We scanned 33 PD patients with “OFF” and “ON” levodopa using Simultaneous Non-Contrast Angiography and intraPlaque Hemorrhage (SNAP) MRA and Pseudo-Continuous Arterial Spin Labeling (PCASL), and used multiple statistical methods to analyze the data. Results from the statistical analysis show that after taking levodopa, patient’s treatment outcomes are highly correlated with his/her gray matter CBF. The results also suggest that levodopa can dilate cerebral arteries and improve CBF, but only in patients with mild symptoms.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords